This is in accordance with Hu et al. (1) and Lyssuk et al. (22) who showed that the CD4+ regulatory T cells and FOXP3 levels in SLE patients were significantly lower than normal controls. The gene discussed is FOXP3; the disease is systemic lupus erythematosus.